Blood Advances · 2018 · 15 citations · 30 references
MedicineMolecular BiologyMolecular GeneticsImmunotherapyMolecular OncologyCancer ImmunotherapyBcr-abl InhibitorsBcr-abl1 Fusion GeneCombination Therapy
Key Points Functional in vivo screening reveals distinct genetic dependencies in a mouse model of BCR-ABL1+ BCP-ALL after dasatinib treatment. Disruption of the PAF/PAFR/PAFAH1B axis sensitizes leukemia cells to TKIs; this pathway may be a novel target for combination therapy.
30
Fast and accurate short read alignment with Burrows–Wheeler transform
Heng Li, Richard Durbin · Bioinformatics · 2009 · 62.8K citations · Full text
Genome engineering using the CRISPR-Cas9 system
F. Ann Ran, Patrick D. Hsu, Jason Wright et al. · Nature Protocols · 2013 · 11.7K citations · Full text
Independent component analysis: algorithms and applications
Aapo Hyvärinen, Erkki Oja · Neural Networks · 2000 · 8.8K citations
A Phase 2 Trial of Ponatinib in Philadelphia Chromosome–Positive Leukemias
Jörge E. Cortes, D. W. Kim, Javier Pinilla‐Ibarz et al. · New England Journal of Medicine · 2013 · 1.1K citations · Full text
Medicine, Oncology, Pharmacology +17